Chris Dobie
Chris completed his PhD in Medicinal Chemistry at the University of Wollongong in 2021 on the rational design of glycosylation inhibitors as anti-metastatic agents, under the supervision of Danielle Skropeta and Haibo Yu. After a brief stint at the TGA, he moved to ANSTO in 2022, and since then has been working across ANSTO and UOW on the development of novel neutron capture agents for Neutron Capture Enhanced Particle Therapy (NCEPT).
Abstracts this author is presenting:
